GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman LlcImmutep Faces Class Action Over TACTI-004 Trial Misstatements
Class action alleges Immutep concealed negative clinical data and misrepresented TACTI-004 trial progress. Investors who purchased shares March 24, 2025–March 12, 2026 may qualify.
IMMPsecurities fraudclass action lawsuit